Chronic in-vivo experience with an endoscopically delivered and retrieved duodenal-jejunal bypass sleeve in a porcine model
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The role of duodenal bypass as an underlying mechanism of action in gastric bypass surgery has received considerable attention. We report the initial feasibility study of a totally endoscopically delivered and retrieved duodenal–jejunal bypass sleeve in a chronic porcine model.
The implant consists of a 60-cm fluoropolymer sleeve that is endoscopically deployed via a coaxial catheter system into the jejunum and fixed in the proximal duodenum with a Nitinol anchor. The system creates a proximal biliopancreatic diversion. Six female Yorkshire pigs were endoscopically implanted; all survived. Four animals (group 1) were slated to survive 90 days, two animals (group 2) for 120 days, and three animals (group 3) underwent sham endoscopy and were survived 120 days. Animals were fed standard dry pig chow 0.5 kg three times daily. Data points included daily general health, weekly weight, serum blood tests (complete blood count, amylase, lipase, liver function tests), and monthly evaluation of anchor/sleeve position/patency by fluoroscopy and endoscopy. Following the in-vivo period, the devices were endoscopically removed and the animals were sacrificed. Duodenal and jejunal tissue samples were assessed histologically.
All six test animals were implanted and explanted without significant adverse events. In group 1, the first animal had no device-related issues. The second animal had a pivoted anchor requiring repositioning at day 63. That animal had no further difficulties. The third animal had an incidental partial rotation of the anchor noted at the 90 day explantation. The fourth animal was incidentally implanted with a crossover of the anchor struts, which was endoscopically corrected on day 14. However, on day 20 the animal had persistent vomiting, and the device was explanted. Both group 2 animals survived 120 days. One animal had a partially rotated anchor but was asymptomatic. The average weight gain between test and sham groups was 0.23 kg/day and 0.42 kg/day, respectively (p = 0.01).
A totally endoscopic and reversible bypass of the duodenum and proximal jejunum has been achieved for 90–120 days. Initial experience suggests patency of the sleeve and acceptable tissue response. Reduced weight gain in the test animals suggests device efficacy. Further investigation is warranted.
- De la Fuente S. DeMaria E. Reynolds J, Porternier D. Pryor A (2007) New developments in surgery: NOTES. Arch Surg 142:295–297 CrossRef
- Garcia-Compean D, Mendoza-Fuerte E, Martinez JA, Villarreal I, Maldonado H (2005) Endoscopic injection of botulinum toxin in the gastric antrum for the treatment of obesity. Results of a pilot study. Gastroenterol Clin Biol 29:789–791 CrossRef
- Gostout CJ, Rajan E (2005) Endoscopic treatments for obesity: past, present and future. Gastroenterol Clin North Am 34:143–150 CrossRef
- Hu B, Chung SC, Sun LC, Kawashima K, Yamamoto T, Cotton PB, Gostout CJ, Hawes RH, Kalloo AN, Kantsevoy SV, Pasricha PJ (2004) Transoral obesity surgery: endolumenal gastroplasty with an endoscopic suture device. Endoscopy 37:411–414 CrossRef
- Rubino F, Forgione A, Cummings DE Vix M, Gnuli D, Mingrone G, Castagneto M, Marescaux J (2006) The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 244:741–749 CrossRef
- Schweitzer M (2004) Endoscopic intraluminal suture plication of the gastric pouch and stoma in post operative Roux y gastric bypass patients. J Laparoendosc Adv Surg Tech 14:223–226
- Chronic in-vivo experience with an endoscopically delivered and retrieved duodenal-jejunal bypass sleeve in a porcine model
Volume 22, Issue 4 , pp 1023-1028
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Department of Surgery, Tufts New England Medical Center, 800 Washington Street, Box 900, Boston, Massachusetts, 02111, USA
- 2. Department of Gastroenterology, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, Massachusetts, 02215, USA
- 3. Department of Surgery, Carolinas Medical Center, 1000 Blythe Blvd, Charlotte, North Carolina, 28203, USA